You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 2.9% | 3.0% |
| Div Cover | 3.1 | 2.9 |
| Op Mrgn | 12.8% | 22.8% |
| ROCE | 15.8% |
| Latest | Forecast | |
|---|---|---|
| P/E | 11.0 | 0.0 |
| PEG | 0.5 | -5.3 |
| Price / Revenue | 1.9 | 1.4 |
| Price / Book value | 2.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 14.2% | 6.6% |
| PBT | 20.6% | n/a |
| EPS | 23.2% | 3.4% |
| DPS | 28.6% | 20.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 2,207.00 | 491.00 | $1.50 | 17.6 | 1.9 | 9% | $0.44 | 1.7% |
| 2020-12-31 | 2,341.00 | 558.00 | $1.73 | 19.9 | 1.3 | 15% | $0.50 | 1.5% |
| 2021-12-31 | 2,553.00 | 544.00 | $1.95 | 15.4 | 1.2 | 13% | $0.54 | 1.8% |
| 2022-12-31 | 2,517.00 | 233.00 | $1.81 | 10.4 | -1.5 | -7% | $0.56 | 3.0% |
| 2023-12-31 | 2,875.00 | 281.00 | $2.23 | 10.2 | 0.4 | 23% | $0.72 | 3.2% |
| London close: Stocks finish lower as Ashtead announces US move Sharecast News | 10 Dec |
|---|---|
| RBC upgrades Hikma Pharmaceuticals to 'outperform' Sharecast News | 10 Dec |
| Hikma reiterates outlook on strong trading Sharecast News | 07 Nov |
| Outcome of Audit Tender Process | 07-Nov-24 15:30 |
|---|---|
| Trading Statement | 07-Nov-24 07:01 |
| 2024 Annual General Meeting Update Statement | 24-Oct-24 07:01 |
| Block listing Interim Review | 01-Oct-24 09:45 |
| Director/PDMR Shareholding | 24-Sep-24 10:09 |